|
Key Benefits of spi-VECTM Oral Delivery Platform
- Safety – Live attenuated bacterial vector has shown a promising safety profile to date in clinical trials of both adults and children
- Oral Delivery – Drinkable vaccine that can be self administered
- Immunogenicity – Designed to induce mucosal and systemic immune response
- Versatility – All-purpose vaccine vector technology designed to deliver a wide range of antigens to prevent/ treat numerous diseases
- Commercial Scale Process – A general cGMP manufacturing process for a stable, lyophilized product has been developed
spi-VEC is a trademark registered in the European Community and owned by
Emergent.
|